Thomas Kaleekal

1.5k total citations · 1 hit paper
44 papers, 1.0k citations indexed

About

Thomas Kaleekal is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Psychiatry and Mental health. According to data from OpenAlex, Thomas Kaleekal has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Psychiatry and Mental health. Recurrent topics in Thomas Kaleekal's work include Transplantation: Methods and Outcomes (19 papers), Epilepsy research and treatment (9 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Thomas Kaleekal is often cited by papers focused on Transplantation: Methods and Outcomes (19 papers), Epilepsy research and treatment (9 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Thomas Kaleekal collaborates with scholars based in United States, India and China. Thomas Kaleekal's co-authors include Amita Srivastava, Sharda Shah Peshin, Gagan Kumar, Elizabeth R. Jacobs, Sergey Tarima, Anand Mohan, Amit Taneja, Edgar Jiménez, Jeff Whittle and Nilay Kumar and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and Journal of Ethnopharmacology.

In The Last Decade

Thomas Kaleekal

39 papers receiving 993 citations

Hit Papers

Nationwide Trends of Severe Sepsis in the 21st Century (2... 2011 2026 2016 2021 2011 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Kaleekal United States 15 387 226 208 153 128 44 1.0k
Atabak Najafi Iran 22 381 1.0× 95 0.4× 461 2.2× 248 1.6× 371 2.9× 156 1.8k
Jack J. M. Ligtenberg Netherlands 22 424 1.1× 445 2.0× 227 1.1× 97 0.6× 176 1.4× 68 1.7k
Hülya Sungurtekin Türkiye 16 208 0.5× 111 0.5× 456 2.2× 99 0.6× 143 1.1× 57 1.1k
Zerrin Defne Dündar Türkiye 16 209 0.5× 181 0.8× 217 1.0× 63 0.4× 110 0.9× 59 702
Kürşat Gündoğan Türkiye 17 233 0.6× 40 0.2× 176 0.8× 89 0.6× 166 1.3× 79 1.2k
Jorge A. Guzmán United States 20 549 1.4× 202 0.9× 338 1.6× 252 1.6× 282 2.2× 65 1.9k
Suman Wason United States 22 150 0.4× 290 1.3× 168 0.8× 30 0.2× 132 1.0× 47 1.1k
Taisuke Jo Japan 22 322 0.8× 112 0.5× 312 1.5× 123 0.8× 513 4.0× 197 2.0k
Mitchell C. Rashkin United States 15 212 0.5× 198 0.9× 114 0.5× 209 1.4× 449 3.5× 25 1.0k
John A. D’Elia United States 24 144 0.4× 122 0.5× 524 2.5× 220 1.4× 492 3.8× 110 2.8k

Countries citing papers authored by Thomas Kaleekal

Since Specialization
Citations

This map shows the geographic impact of Thomas Kaleekal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kaleekal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kaleekal more than expected).

Fields of papers citing papers by Thomas Kaleekal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kaleekal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kaleekal. The network helps show where Thomas Kaleekal may publish in the future.

Co-authorship network of co-authors of Thomas Kaleekal

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kaleekal. A scholar is included among the top collaborators of Thomas Kaleekal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kaleekal. Thomas Kaleekal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Scullin, Daniel C., et al.. (2024). Acute Graft versus Host Disease in a Lung Transplant Recipient. The Journal of Heart and Lung Transplantation. 43(4). S489–S490.
3.
Okumura, Kenji, Soma Jyothula, Thomas Kaleekal, & Abhay Dhand. (2023). 1-Year Outcomes of Lung Transplantation for Coronavirus Disease 2019–Associated End-Stage Lung Disease in the United States. Clinical Infectious Diseases. 76(12). 2140–2147. 5 indexed citations
4.
Nellore, Anoma, Keith Wille, Daniel C. Scullin, et al.. (2022). Bilateral Lung Transplantation With Donor Positive for COVID-19 Infection on Bronchoalveolar Lavage: A Case Report. Transplantation Proceedings. 55(3). 540–542. 1 indexed citations
5.
Kumar, Sachin, et al.. (2022). Antiepileptic-drug tapering and seizure recurrence. Indian Journal of Pharmacology. 54(1). 24–32. 2 indexed citations
7.
Patel, Vipul, et al.. (2020). Primary lung carcinoma in cystic fibrosis: A case report and literature review. Respiratory Medicine Case Reports. 31. 101242–101242. 3 indexed citations
8.
Chandra, P. Prarthana, et al.. (2020). Adjuvant role of Ocimum sanctum hydroalcoholic extract with carbamazepine and phenytoin in experimental model of acute seizures. Saudi Pharmaceutical Journal. 28(11). 1440–1450. 5 indexed citations
9.
Kaleekal, Thomas, et al.. (2019). Postoperative Horner Syndrome After Lung Transplantation. Journal of Neuro-Ophthalmology. 40(4). 504–506. 4 indexed citations
10.
Chan, Edward Y., Duc T. Nguyen, Thomas Kaleekal, et al.. (2019). The Houston Methodist Lung Transplant Risk Model: A Validated Tool for Pretransplant Risk Assessment. The Annals of Thoracic Surgery. 108(4). 1094–1100. 5 indexed citations
11.
Chan, Edward Y., Ahmad Goodarzi, Neeraj Sinha, et al.. (2018). Long-Term Survival in Bilateral Lung Transplantation for Scleroderma-Related Lung Disease. The Annals of Thoracic Surgery. 105(3). 893–900. 19 indexed citations
12.
Sinha, Neeraj, J. DeVos, Thomas Kaleekal, et al.. (2017). Early clearance vs persistence of de novo donor‐specific antibodies following lung transplantation. Clinical Transplantation. 31(8). 21 indexed citations
13.
Kumar, Ritesh, et al.. (2017). Pharmacokinetic and pharmacodynamic interaction of hydroalcoholic extract of Ocimum sanctum with valproate. Epilepsy & Behavior. 75. 203–209. 11 indexed citations
14.
Gulati, Sheffali, Puneet Jain, Shivaram Shastri, et al.. (2015). Prevalence of UGT1A6 polymorphisms in children with epilepsy on valproate monotherapy. Neurology India. 63(1). 35–35. 12 indexed citations
15.
Dwivedi, Rekha, Meenakshi Singh, Thomas Kaleekal, Yogendra Kumar Gupta, & Manjari Tripathi. (2015). Concentration of antiepileptic drugs in persons with epilepsy: a comparative study in serum and saliva. International Journal of Neuroscience. 126(11). 972–978. 18 indexed citations
16.
Kumar, Gagan, Nilay Kumar, Amit Taneja, et al.. (2011). Nationwide Trends of Severe Sepsis in the 21st Century (2000–2007). CHEST Journal. 140(5). 1223–1231. 483 indexed citations breakdown →
17.
Kaleekal, Thomas, et al.. (2010). Cavitating Bronchioloalveolar Carcinoma: An Unusual Radiological Presentation. CHEST Journal. 138(4). 20A–20A. 2 indexed citations
19.
Kaleekal, Thomas, et al.. (2004). Multiple Saphenous Vein Graft Aneurysms: A late complication of Coronary Artery Bypass Surgery. CHEST Journal. 126(4). 934S–934S. 2 indexed citations
20.
Gupta, SK, Thomas Kaleekal, & Sujata Joshi. (2000). Misuse of corticosteroids in some of the drugs dispensed as preparations from alternative systems of medicine in India. Pharmacoepidemiology and Drug Safety. 9(7). 599–602. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026